Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain

Changes in Cognition and Amyloid-β Processing with Long Term Cholesterol Reduction using Atorvastatin in Aged Dogs

(2017) M. Paul Murphy et al.   JOURNAL OF ALZHEIMERS DISEASE

The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development

(2012) C. Mancuso et al.   CURRENT DRUG METABOLISM

Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment

(2011) Eugenio Barone et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Current perspectives on pharmacotherapy of Alzheimer's disease

(2011) Kanwaljit Chopra et al.   EXPERT OPINION ON PHARMACOTHERAPY

The Yeast Homolog of Heme Oxygenase-1 Affords Cellular Antioxidant Protection via the Transcriptional Regulation of Known Antioxidant Genes

(2010) Emma J. Collinson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

(2010) H. H. Feldman et al.   NEUROLOGY

Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action

(2010) Eugenio Barone et al.   PHARMACOLOGICAL RESEARCH

Therapeutic potential of statins in Alzheimer's disease

(2009) Nagaendran Kandiah et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Pharmacological Preconditioning With Simvastatin Protects Liver From Ischemia-Reperfusion Injury by Heme Oxygenase-1 Induction

(2009) I-Rue Lai et al.   TRANSPLANTATION

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

(2008) A. Blum et al.   ATHEROSCLEROSIS

Regulation of glutathione synthesis

(2008) Shelly C. Lu   MOLECULAR ASPECTS OF MEDICINE